BAYN.DE CHMP opinion: Thursday, July 23, 2026
Variation type II · Xofigo · Submission of final study report from study 20511 listed in Annex IID of the SmPC. This is a phase I biodistribution study to further characterise correlation between the extent of the disease, the dose and the distribution of radium-223 in bone metastases versus sites o
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.